Browse diseases

…st that when sulfonylureas must be used for glucose-lowering in T2D, clinicians may want to avoid glipizide and prioritize glimepir…

…and new-onset arrhythmias (5.3% vs 0.2%; p<0.001), particularly atrial fibrillation (7.1% vs 1.7%; p=0.011). Dual biomarker elevation was associate…

…stract 2-002 Figure 2Patient flow through invasive CFT service. ANOCA - angina with unobstructed coronary arteriesReferences Vrints C…

…25 – 84.Case selection: Identification of consecutive events of myocardial infarction. Assessment of angiogram to confirm flow limiting disease. Tota…